Company Profiles

driven by the PitchBook Platform

ArisGen

Description

Developer of formulation technology focused on the treatment of metabolic diseases and oncology. The company's formulation technology, ArisCrown, enables delivery of therapeutic peptides through oral, buccal or sub-lingual routes and transforms the injectable peptide market offering oral alternatives for these medications.

2006

Founded

PRIVATE

Status

1-10

Employees

Accelerator/Inc

Latest Deal Type

1

Investors

Description

Developer of formulation technology focused on the treatment of metabolic diseases and oncology. The company's formulation technology, ArisCrown, enables delivery of therapeutic peptides through oral, buccal or sub-lingual routes and transforms the injectable peptide market offering oral alternatives for these medications.

Website:

www.arisgen.com

Ownership Status

Privately Held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Drug Delivery

Other Industries

Other Devices and Supplies
Biotechnology

Primary Office

Chemin des Aulx,14 1228 Plan-les-Ouates GenevaSwitzerland +41 (0)22 880 1016
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore ArisGen's full profile, request a free trial.

    ArisGen Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    ArisGen Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Swiss Startup InvestOtherMinority000 0000000 0000
    Swiss Startup Invest Other

    ArisGen Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Paolo Botti Ph.DChief Scientific Officer, Board Member and Founder
    Christophe GuichardChief Financial Officer
    Paolo Botti Ph.D Chief Scientific Officer, Board Member and Founder
    Christophe Guichard Chief Financial Officer

    ArisGen Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    Jesús Martin-GarciaSelfChairman000 0000
    Paolo Botti Ph.DArisGenChief Scientific Officer, Board Member and Founder000 0000
    Jesús Martin-Garcia Chairman Self
    Paolo Botti Ph.D Chief Scientific Officer, Board Member and Founder ArisGen
    Request full access to PitchBook